These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 20488299)

  • 1. Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis.
    Schneider MP; Hua TA; Böhm M; Wachtell K; Kjeldsen SE; Schmieder RE
    J Am Coll Cardiol; 2010 May; 55(21):2299-307. PubMed ID: 20488299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications.
    Lévy S
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):220-5. PubMed ID: 16568131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-angiotensin system inhibitors for prevention of recurrent atrial fibrillation: a meta-analysis.
    Li TJ; Zang WD; Chen YL; Geng N; Ma SM; Li XD
    Int J Clin Pract; 2013 Jun; 67(6):536-43. PubMed ID: 23557493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the renin-angiotensin system for prevention of atrial fibrillation.
    Zografos T; Katritsis DG
    Pacing Clin Electrophysiol; 2010 Oct; 33(10):1270-85. PubMed ID: 20636314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).
    Palardy M; Ducharme A; Nattel S; Tardif JC; White M; Racine N; Tétreault K; Dabouz F; Talajic M; Roy D;
    Can J Cardiol; 2008 Sep; 24(9):709-13. PubMed ID: 18787722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of RAAS Blockers on Atrial Fibrillation Prophylaxis: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Chaugai S; Meng WY; Ali Sepehry A
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):388-404. PubMed ID: 26817632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of renin-angiotensin system blockade therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials.
    Zhang Y; Zhang P; Mu Y; Gao M; Wang JR; Wang Y; Su LQ; Hou YL
    Clin Pharmacol Ther; 2010 Oct; 88(4):521-31. PubMed ID: 20811347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of inhibition of renin-angiotensin system on cardioversion success and recurrences of atrial fibrillation].
    Doğan A; Akçay S
    Anadolu Kardiyol Derg; 2009 Dec; 9(6):505-11. PubMed ID: 19965325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reviewing the future of renin-angiotensin system blockade: the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation.
    Ducharme A; Schiffrin EL
    Can J Cardiol; 2010 Dec; 26 Suppl E():21E-23E. PubMed ID: 21620287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Unsatisfactory results of upstream therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for the prevention of recurrent atrial fibrillation].
    Disertori M; Zeni P; Quintarelli S; Bonmassari R
    G Ital Cardiol (Rome); 2010 Nov; 11(11):829-34. PubMed ID: 21348320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis.
    Jibrini MB; Molnar J; Arora RR
    Am J Ther; 2008; 15(1):36-43. PubMed ID: 18223352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of pretreatment with renin-angiotensin-aldosterone system blockers on cardioversion success and acute recurrence of atrial fibrillation.
    Dogan A; Akcay S; Karabacak M; Turker Y; Ozaydin M; Erdogan D
    Int J Clin Pract; 2009 Jul; 63(7):1017-23. PubMed ID: 19570119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.
    Healey JS; Baranchuk A; Crystal E; Morillo CA; Garfinkle M; Yusuf S; Connolly SJ
    J Am Coll Cardiol; 2005 Jun; 45(11):1832-9. PubMed ID: 15936615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation.
    Anand K; Mooss AN; Hee TT; Mohiuddin SM
    Am Heart J; 2006 Aug; 152(2):217-22. PubMed ID: 16875900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin system inhibitors prevent the recurrence of atrial fibrillation: a meta-analysis of randomized controlled trials.
    Han M; Zhang Y; Sun S; Wang Z; Wang J; Xie X; Gao M; Yin X; Hou Y
    J Cardiovasc Pharmacol; 2013 Oct; 62(4):405-15. PubMed ID: 23921300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-angiotensin system inhibition is associated with reduced risk of left atrial appendage thrombosis formation in patients with atrial fibrillation.
    Suo Y; Zhang Y; Wang Y; Yuan M; Kariyawasam S; Tse G; Liu T; Fu H; Li G
    Cardiol J; 2018; 25(5):611-620. PubMed ID: 28980280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation: Blockade of the renin-angiotensin system in atrial fibrillation.
    Kuzniatsova N; Shantsila E; Lip GY
    Nat Rev Cardiol; 2010 Aug; 7(8):428-30. PubMed ID: 20657612
    [No Abstract]   [Full Text] [Related]  

  • 20. Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction.
    Arslan A; Ozaydin M; Aksoy F; Arslan B; Bas HA; Erdogan D; Varol E; Dogan A
    Medicina (Kaunas); 2016; 52(2):104-9. PubMed ID: 27170483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.